Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Human TIGIT Antibody, R&D Systems™
GREENER_CHOICE

Mouse Monoclonal Antibody

Supplier:  R&D Systems MAB78981SP

 View more versions of this product

Catalog No. MAB78981SP


Only null left
Add to Cart
This item is not returnable. View return policy

Description

Description

TIGIT Monoclonal specifically detects TIGIT in Human samples. It is validated for Blockade of Receptor-ligand Interaction.
Specifications

Specifications

TIGIT
Monoclonal
Unconjugated
Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS.
Mouse
Protein A or G purified from hybridoma culture supernatant
RUO
201633
Reconstitute at 0.5 mg/mL in sterile PBS.
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.
Blockade of Receptor-ligand Interaction
741170
Blockade of Receptor-ligand Interaction 70-350 ng/mL
Q495A1
Mouse myeloma cell line NS0-derived recombinant human TIGIT Met1-Pro141 Accession # Q495A1
25 μg
Primary
Detects human TIGIT in direct ELISAs.
Human
IgG1
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.